BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 18496675)

  • 1. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
    Jacobsen JP; Nielsen EØ; Hummel R; Redrobe JP; Mirza N; Weikop P
    Psychopharmacology (Berl); 2008 Aug; 199(2):137-50. PubMed ID: 18496675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity.
    Calcagno E; Canetta A; Guzzetti S; Cervo L; Invernizzi RW
    J Neurochem; 2007 Nov; 103(3):1111-20. PubMed ID: 17666043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
    Stenfors C; Yu H; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.
    Jin ZL; Chen XF; Ran YH; Li XR; Xiong J; Zheng YY; Gao NN; Li YF
    Sci Rep; 2017 Aug; 7(1):8631. PubMed ID: 28819255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects in various mice strains in the tail suspension test.
    Ripoll N; David DJ; Dailly E; Hascoët M; Bourin M
    Behav Brain Res; 2003 Aug; 143(2):193-200. PubMed ID: 12900045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats.
    Yoshitake T; Kehr J
    Life Sci; 2004 Apr; 74(23):2865-75. PubMed ID: 15050424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.
    Ferrés-Coy A; Santana N; Castañé A; Cortés R; Carmona MC; Toth M; Montefeltro A; Artigas F; Bortolozzi A
    Psychopharmacology (Berl); 2013 Jan; 225(1):61-74. PubMed ID: 22820867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study.
    Dawson LA; Nguyen HQ; Smith DI; Schechter LE
    Br J Pharmacol; 2000 Jun; 130(4):797-804. PubMed ID: 10864885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept.
    Jacobsen JP; Rudder ML; Roberts W; Royer EL; Robinson TJ; Oh A; Spasojevic I; Sachs BD; Caron MG
    Neuropsychopharmacology; 2016 Aug; 41(9):2324-34. PubMed ID: 26932820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
    Tao R; Ma Z; Auerbach SB
    J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test.
    Miyata S; Hirano S; Kamei J
    Neuropsychopharmacology; 2004 Mar; 29(3):461-9. PubMed ID: 14628002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
    Bortolozzi A; Castañé A; Semakova J; Santana N; Alvarado G; Cortés R; Ferrés-Coy A; Fernández G; Carmona MC; Toth M; Perales JC; Montefeltro A; Artigas F
    Mol Psychiatry; 2012 Jun; 17(6):612-23. PubMed ID: 21808255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.